What are the top competitors of Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) in the Healthcare sector?

9960.HK's main Healthcare peers include WuXi AppTec Co., Ltd. (2359.HK), WuXi XDC Cayman Inc (2268.HK), Joinn Laboratories(China)Co.,Ltd. (6127.HK), Adicon Holdings Limited (9860.HK), Beijing Airdoc Technology Co., Ltd. (2251.HK), based on companies in the Medical - Diagnostics & Research industry.

Which has better valuations and earnings, Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) or its competitors?

On the HKSE, 9960.HK trades at a P/E of -14.05 with EPS of $-0.07, which can be compared directly against peers such as 2359.HK (P/E 23.53) in the table above.

Which stock is more profitable: Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) or its competitors?

9960.HK on the HKSE posts an ROE of -0.02%, versus 2359.HK's 0.27% — 9960.HK shows weaker profitability than 2359.HK.

What is Kindstar Globalgene Technology, Inc.'s (HKSE: 9960.HK) stock volatility and risk?

On the HKSE, 9960.HK is more volatile relative to peers like 2359.HK, indicating higher risk for short-term traders.

Is Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) stock profitable?

9960.HK on the HKSE reports EPS of $-0.07 and an ROE of -0.02%, indicating it is not profitable based on current EPS and ROE.

What is Kindstar Globalgene Technology, Inc.'s (HKSE: 9960.HK) 52-week high and low?

Over the past 52 weeks, 9960.HK on the HKSE has traded between $0.91 and $1.56.

What was the average volume of Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) stock?

9960.HK's average trading volume on the HKSE is 405.7K.

Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) Stock Competitors & Peer Comparison

See 9960.HK's competitors and their performance on the HKSE and across the wider stock market.

9960.HK●HKSE

HealthcareMedical - Diagnostics & Research

HK$0.92

HK$0.00(0.00%)

Hong Kong Market opens in 6h 29m

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for 9960.HK and its HKSE peers.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
9960.HK	HK$0.92	+0.00%	955.8M	-14.05	-HK$0.07	+10.27%
2359.HK	HK$199.80	+1.06%	591.4B	23.53	HK$8.68	+1.17%
2268.HK	HK$77.25	+10.67%	101.5B	62.96	HK$1.27	N/A
6127.HK	HK$24.94	+3.83%	34.6B	33.29	HK$0.76	+0.55%
9860.HK	HK$3.58	-3.24%	2.7B	84.42	HK$0.04	N/A
2251.HK	HK$9.52	-8.46%	966.9M	-35.89	-HK$0.27	N/A
8037.HK	HK$0.61	-1.61%	605M	-3.03	-HK$0.20	N/A
2325.HK	HK$0.61	-5.47%	348.3M	-1.29	-HK$0.46	N/A
8247.HK	HK$3.24	+1.25%	201.2M	-7.63	-HK$0.41	N/A
0928.HK	HK$0.11	-1.87%	190.6M	13.29	HK$0.01	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WuXi AppTec Co., Ltd. (HKSE: 2359.HK)

9960.HK vs 2359.HK Comparison August 2026

Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) plays a significant role within the Healthcare sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9960.HK stands at 955.8M. In comparison, 2359.HK has a market cap of 591.4B. Regarding current trading prices, 9960.HK is priced at HK$0.92 on the HKSE, while 2359.HK trades at HK$199.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9960.HK currently has a P/E ratio of -14.05, whereas 2359.HK's P/E ratio is 23.53. In terms of profitability, 9960.HK's ROE is -0.02%, compared to 2359.HK's ROE of +0.27%. Regarding short-term risk, 9960.HK is more volatile compared to 2359.HK. This indicates higher risk in terms of short-term price fluctuations for 9960.HK.Check 2359.HK's competition here

Kindstar Globalgene Technology, Inc. (HKSE: 9960.HK) Stock Competitors & Peer Comparison

Peer Comparison Table: Medical - Diagnostics & Research Industry

Stock Comparison

WuXi AppTec Co., Ltd. (HKSE: 2359.HK)

9960.HK vs 2359.HK Comparison August 2026

WuXi XDC Cayman Inc (HKSE: 2268.HK)

9960.HK vs 2268.HK Comparison August 2026

Joinn Laboratories(China)Co.,Ltd. (HKSE: 6127.HK)

9960.HK vs 6127.HK Comparison August 2026

Adicon Holdings Limited (HKSE: 9860.HK)

9960.HK vs 9860.HK Comparison August 2026

Beijing Airdoc Technology Co., Ltd. (HKSE: 2251.HK)

9960.HK vs 2251.HK Comparison August 2026

China Biotech Services Holdings Limited (HKSE: 8037.HK)

9960.HK vs 8037.HK Comparison August 2026

Yunkang Group Limited (HKSE: 2325.HK)

9960.HK vs 2325.HK Comparison August 2026

Biosino Bio-Technology & Science Inc. (HKSE: 8247.HK)

9960.HK vs 8247.HK Comparison August 2026

King International Investment Limited (HKSE: 0928.HK)

9960.HK vs 0928.HK Comparison August 2026

Stock price comparison of stocks in the Healthcare Sector

Frequently Asked Questions